Topical Lidocaine During Airway Manipulation in Pediatric Anesthesia: A Systematic Review and Meta-Analysis
- PMID: 41216993
- DOI: 10.1111/pan.70077
Topical Lidocaine During Airway Manipulation in Pediatric Anesthesia: A Systematic Review and Meta-Analysis
Abstract
Introduction: Lidocaine is widely used in pediatric anesthesia for airway topicalization to modulate undesirable airway and circulatory reflexes, yet its effectiveness remains unclear. Therefore, we aimed to perform a meta-analysis evaluating the impact of topical lidocaine on respiratory adverse events in children undergoing airway management.
Methods: PubMed, Embase, and Cochrane databases were systematically searched for studies comparing topical lidocaine with placebo, no intervention, or intravenous lidocaine for pediatric airway management. Statistical analysis was performed using R (version 4.4.1). Odds ratios (ORs) were used for binary outcomes and mean differences for continuous outcomes, with 95% confidence intervals (CIs) computed using a random-effects model.
Results: Fourteen randomized controlled trials comprising 1937 pediatric patients were included, of whom 917 (47%) received airway topicalization. In those receiving topical lidocaine, there was a significant reduction in the incidence of laryngospasm (OR 0.50; 95% CI 0.27 to 0.95; p = 0.033), desaturation (OR 0.49; 95% CI 0.25 to 0.98; p = 0.043), and sore throat (OR 0.31; 95% CI 0.16 to 0.58; p < 0.001). However, no significant differences were observed for bronchospasm (OR 0.50; 95% CI 0.11 to 2.35; p = 0.382), cough (OR 0.56; 95% CI 0.28 to 1.11; p = 0.099), severe cough (OR 1.30; 95% CI 0.18 to 9.51; p = 0.793), hoarseness (OR 1.41; 95% CI 0.17 to 11.96; p = 0.754), vomiting (OR 1.95; 95% CI 0.47 to 7.99; p = 0.355), and heart rate (beats/min) (MD 0.08; 95% CI -6.31 to 6.47; p = 0.98).
Conclusion: Our findings suggest that topical lidocaine may reduce the incidence of undesirable airway reflexes such as laryngospasm, desaturation, and sore throat in children undergoing airway management. However, its benefit for other perioperative respiratory adverse events requires further investigation, especially in high-risk populations.
Trial registration: PROSPERO registration number: CRD42024614863.
Keywords: adverse events; airway management; lidocaine; pediatric anesthesia; topical drug administration.
© 2025 The Author(s). Pediatric Anesthesia published by John Wiley & Sons Ltd.
References
-
- E. A. Hall, H. E. Sauer, M. S. Davis, and D. L. Anghelescu, “Lidocaine Infusions for Pain Management in Pediatrics,” Paediatric Drugs 23, no. 4 (2021): 349–359.
-
- N. M. Dave, “Premedication and Induction of Anaesthesia in Paediatric Patients,” Indian Journal of Anaesthesia 63, no. 9 (2019): 713–720.
-
- S. A. Khan and M. Matuszczak, “Management of the Pediatric Difficult Airway: New Strategies Unveiled,” Current Anesthesiology Reports 14 (2024): 417–425.
-
- N. Disma, T. Asai, E. Cools, et al., “Airway Management in Neonates and Infants: European Society of Anaesthesiology and Intensive Care and British Journal of Anaesthesia Joint Guidelines,” British Journal of Anaesthesia 132 (2024): 124–144.
-
- H. A. Iliff, J. Parnell, P. A. Baker, et al., “Consensus Recommendations for Paediatric Airway Topicalisation Using Lidocaine,” Anaesthesia 80 (2025): 1237–1246.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
